News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Quimi Daphne
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| Quimi Daphne (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 06/12/2023 |
4
| Quimi Daphne (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 16,985 options to buy
@ $26.25, valued at
$445.9k
|
|
| 01/19/2023 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 5,000 shares
@ $12.4889, valued at
$62.4k
Sold 6,923 shares
@ $13, valued at
$90k
|
|
| 01/13/2023 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 58,824 shares
@ $0
Paid exercise price by delivering 29,565 shares
@ $12.02, valued at
$355.4k
|
|
| 01/06/2023 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 3,884 shares
@ $12.03, valued at
$46.7k
|
|
| 01/04/2023 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 15,165 shares
@ $12.21, valued at
$185.2k
Granted 73,508 shares
@ $0
Paid exercise price by delivering 8,575 shares
@ $11.93, valued at
$102.3k
Granted 130,480 options to buy
@ $11.93, valued at
$1.6M
|
|
| 10/03/2022 |
4
| Quimi Daphne (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 39,744 options to buy
@ $9.89, valued at
$393.1k
|
|
| 09/06/2022 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 4,397 shares
@ $11.2851, valued at
$49.6k
|
|
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 36,840 shares
@ $0
Paid exercise price by delivering 18,843 shares
@ $10.53, valued at
$198.4k
|
|
| 01/10/2022 |
4
| Quimi Daphne (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 8,400 options to buy
@ $19, valued at
$159.6k
|
|
| 01/04/2022 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 10,502 shares
@ $11.55, valued at
$121.3k
Paid exercise price by delivering 15,778 shares
@ $11.55, valued at
$182.2k
Paid exercise price by delivering 1,538 shares
@ $12.11, valued at
$18.6k
Granted 73,136 shares
@ $0
Paid exercise price by delivering 4,041 shares
@ $12.48, valued at
$50.4k
Granted 134,044 options to buy
@ $12.11, valued at
$1.6M
|
|
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 5,000 shares
@ $24.0947, valued at
$120.5k
Exercised 5,000 options to buy
@ $2.94, valued at
$14.7k
|
|
| 12/17/2020 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 4,156 shares
@ $23.86, valued at
$99.2k
Exercised 11,500 options to buy
@ $2.94, valued at
$33.8k
Exercised 7,550 options to buy
@ $4.38, valued at
$33.1k
Exercised 4,379 options to buy
@ $3.53, valued at
$15.5k
Exercised 6,892 options to buy
@ $2.45, valued at
$16.9k
|
|
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,046 shares
@ $11.14, valued at
$11.7k
|
|
| 04/03/2020 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 4,803 shares
@ $0 |
|
| 01/14/2020 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 24,496 shares
@ $0
Paid exercise price by delivering 12,065 shares
@ $9.46, valued at
$114.1k
|
|
| 01/10/2020 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 15,000 shares
@ $9.9301, valued at
$149k
Exercised 9,822 options to buy
@ $2.52, valued at
$24.8k
Exercised 1,200 options to buy
@ $4.38, valued at
$5.3k
|
|
| 01/06/2020 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 7,113 shares
@ $9.55, valued at
$67.9k
Paid exercise price by delivering 5,305 shares
@ $9.18, valued at
$48.7k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2019 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,046 shares
@ $11.35, valued at
$11.9k
|
|
| 04/15/2019 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 12,347 shares
@ $0 |
|
| 01/10/2019 |
4
| Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 57,471 shares
@ $0
Paid exercise price by delivering 3,850 shares
@ $10.33, valued at
$39.8k
Granted 88,154 options to buy
@ $10.04, valued at
$885.1k
|
|
| 03/12/2018 |
4
| Quimi Daphne (SVP, Finance) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Sold 8,750 shares
@ $15, valued at
$131.3k
Exercised 8,750 options to buy
@ $5.96, valued at
$52.2k
|
|
| 03/05/2018 |
4
| Quimi Daphne (SVP, Finance) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Sold 8,149 shares
@ $14.0553, valued at
$114.5k
Exercised 8,149 options to buy
@ $4.16, valued at
$33.9k
|
|
| 01/05/2018 |
4
| Quimi Daphne (SVP, Finance) has filed a Form 4 on AMICUS THERAPEUTICS INC|
Txns:
| Granted 12,609 shares
@ $0
Paid exercise price by delivering 2,953 shares
@ $15.67, valued at
$46.3k
Granted 18,224 options to buy
@ $15.67, valued at
$285.6k
|
|
|
|
|